Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Torbjorn Omland is a professional business entity and sole proprietorship based in Norway, operated by Professor Torbjørn Omland, a globally recognized expert in cardiovascular medicine and biomarker research. The entity provides specialized consulting, clinical research services, and advisory expertise to the pharmaceutical, biotechnology, and diagnostic industries. Professor Omland's work primarily focuses on the validation and clinical application of cardiac biomarkers, such as high-sensitivity troponins and natriuretic peptides, to improve the diagnosis and risk stratification of heart failure and coronary artery disease. This entity serves as a vehicle for his professional contributions to international clinical trials and academic-industrial collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Torbjorn Omland.